Abstract
SUMMARY
1. Nicotine and its main derivative, cotinine, are reported to have distinct central activities in mammals. In this study, the cotinine receptor was separated by biochemical procedures including radio receptor, affinity-chromatography, SDS–PAGE, and N-terminal sequencing assays.
2. Consistently, the results showed that distinctive cotinine receptors exist in different tissues of mammals. In rat brain, the affinity chromatography and [125I]cotinine receptor essays were used to isolate a 40-kDa protein (p40) with higher affinity for cotinine than alpha-bungarotoxin and nicotine. The N-terminus amino acid sequences of the p40 and its internal tryptic peptides showed no identity to recently described protein sequences, with the exception of homology to the human p205 synovial fluid protein.
3. These results, in agreement with other behavioral studies, are the first molecular evidence for distinctive nicotine and cotinine receptors in mammals.
Similar content being viewed by others
REFERENCES
Anderson, D. J., and Arneric, S. P. (1994). Nicotinic receptor binding of (3H)nicotine, (3H)cytisine and (3H)methylcarbamylcholine in rat brain. Eur. J. Pharmacol. 253:261-267.
Andersson, K., Jansson, A., Kuylenstierna, F., and Eneroth, P. (1993). Nicotine and its major metabolite cotinine have different effects on aldosterone and prolactin serum levels in the normal rat. Eur. J. Pharmacol. 228:305-312.
Barrantes, F. J. (1997). The acetylcholine receptor ligand-gated channels as a molecular target of disease and therapeutic agents. Neurochem. Res. 22:391-400.
Bradford, M. M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Annal. Biochem. 72:249-254.
Chahine, R., Aftimos, G., Wainberg, M. C., Navarro-Delmasure, C., and Abou Khalil, K. (1996). Cotinine modulates the cardiovascular effects of nicotine. Med. Sci. Res. 24:21-23.
Chahine, R., Calderone, A., and Navarro-Delmasure, C. (1990). The in vitro effects of nicotine and cotinine on prostacyclin and thromboxane biosynthesis. Prostaglandins Leukotrienes Essential Fatty Acids 40:261-263.
Chahine, R., Navarro-Delmasure, C., Chanh, P. H., Abou Assali, M., and Kastoun, E. (1993). Effects of nicotine and cotinine on noradrenergic transmission in the heart. Med. Sci. Res. 21:421-422.
Decker, M. W., and Meyer, M. D. (1999). Therapeutic potential of neuronal nicotinic acetylcholine receptor agonists as novel analgesics. Biochem. Pharmacol. 58:917-923.
Devereux, J., Harberli, P., and Smithies, O. (1984). A comprehensive set of sequencing analysis programs for the vax. Nucleic Acids Res. 12:387.
Dwonski, L. P., Teng, L., Buxton, S. T., and Crooks, P. A. (1999). (S)-(_)-Cotinine, the major brain metabolite of nicotine, stimulates nicotinic receptors to evoke (3H)dopamine release from rat striatal slices in a calcium-dependent manner. J. Pharmacol Exp. Ther. 288:905-1011.
Fuxe, K., Everitt, B. J., and Hökfelt, T. (1978). On the action of nicotine and cotinine on central 5-hydroxytryptamine neurons. Pharmacol. Biochem. Behav. 10:671-677.
Goldberg, S. R., Risner, M. E., Stolerman, I. P., Reavill, C., and Garcha, H. S. (1989). Nicotine and some related compounds: Effects on schedule-controlled behavior and discriminative properties in the rat. Psychopharmacology 97:295-302.
Hain, N. A. K., Stuhlmüller, B., Hahn, G. R., Kalden, J. R., Deutzmann, R., and Burmester, G. R. (1996). Biochemical characterization and microsequencing of a 205-kDa synovial protein stimulatory for T cells and reactive with rheumatoid factor containing sera. J. Immunol. 157:1773-1780.
Hatsukami, D., Pentel, P. R., Jensen, J., Nelson, D., Allen, S. S., Goldman, A., and Rafael, D. (1998). Cotinine: Effects with and without nicotine. Psychopharmacology 135:141-150.
Herzig, K. E., Callaway, E., Halliday, R., Naylor, H., and Benowitz, N. L. (1998). Effects of cotinine on information processing in non smokers. Psychopharmacology (Berl.) 135:127-132.
Holloway, P. W. (1973). A simple procedure of removal of Triton X100 from protein samples. Anal. Biochem. 53:304-308.
Keenan, R., Hatsukami, D., Rentel, P., Thompson, T., and Grillo, M. (1994). Pharmacodynamics of effects of cotinine in abstinent cigarette smokers. Clin. Pharmacol. Ther. 55:581-590.
Kim, K. S., Borzelleca, J. F., Bowman, E. R., and McKennis, H. (1968). Effects of some nicotine metabolites and related compounds on isolated smooth muscle. J. Pharmacol. Exp. Ther. 161:59-69.
Laemmli, U. K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680.
Leatherbarrow, R. J. (1987). ENZFITTER: A Non-Linearly Regression Data Analysis Program for the IBM PC (and True Compatible). Elsevier, Amsterdam.
Lena, C., and Changeux, J. P. (1997). Pathological mutations of nicotinic receptors and nicotine-based therapies for brain disorders. Curr. Opin. Neurobiol. 7:674-682.
MacGehee, D., Heath, M. J. S., Gelber, S., Devay, P., and Role, L. W. (1995). Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors. Science 269:1692-1696.
Martyn, J. A. (1995). Basic and clinical pharmacology of the acetylcholine receptor: Implication for the use of neuromuscular relaxants. Keio J. Med. 44:1-8.
Marubio, L. M., del Mar Arroyo-Jimenez, M., Cordero-Erausquin, M., Lena, C., Le Novere, N., de Kerchove d'Exaerde, A., Huchet, M., Damaj, M. I., and Changeux, J. P. (1999). Reduced antinociception in mice lacking neuronal nicotinic receptor subunits. Nature 29:805-810.
Pianezza, M. L., Sellers, E. M., and Tyndale, R. F. (1998). Nicotine metabolism defect reduces smoking. Nature 393:750.
Picciotto, M. R., Zoli, M., Rimondin, R., Lena, C., Marubio, L. M., Pich, E. M., Fuxe, K., and Changeux, J. P. (1998). Acetylcholine receptors containing the β-2 subunit are involved in the reinforcing properties of nicotine. Nature 39:173-177.
Riah, O., Courrière, Ph., Dousset, J. C., Todeschi, N., and Labat, C. (1998). Nicotine is more efficient than cotinine at passing the blood-brain barrier in rats. Cell. Mol. Neurobiol. 18:311-318.
Riah, O., Dousset, J. C., Courrière, Ph., Baziaed-Mouysset, G., and Ecalle, R. (1997). Synthesis of cotinine and cotinine N-oxide: Evaluation of their interaction with nicotine in the insecticidal activity. Nat. Prod. Lett. 11:37-45.
Riah, O., Dousset, J. C., Courrière, Ph., Stigliani, J. L., Baziaed-Mouysset, G., and Belahsen, Y. (1999). Evidence that nicotine acetylcholine receptors are not the main targets of cotinine toxicity. Toxicol. Lett. 109:21-29.
Risner, M. E., Cone, E. J., Benowitz, N. L., and Jacob, III, P. (1988). Effects of the stereoisomers of nicotine and nornicotine on schedule-controlled responding and physiological parameters of dogs. J. Pharmacol. Exp. Ther. 244:807-813.
Risner, M. E., Goldberg, S. R., Prada, J. A., and Cone, E. J. (1985). Effects of nicotine, cocaine and some of their metabolites on schedule-controlled responding by beagle dogs and squirrel monkeys. J. Pharmacol. Exp. Ther. 244:807-813.
Role, L. W. (1992). Diversity in primary structure and function of neuronal nicotinic acetylcholine receptor channels. Curr. Opin. Neurobiol. 2:254-262.
Romano, C., and Goldstein, A. (1980). Stereospecific nicotine receptors in rat brain membranes. Sciences 210:647-650.
Sargent, P. B. (1993). The diversity of neuronal nicotinic acetylcholine receptors. Annu. Rev. Neurosci 16:403-443.
Sloan, J. W., Todd, J. D., and Martin, W. R. (1984). Nature of nicotine binding to rat brain P2 fraction. Pharmacol. Biochem. Behav. 20:899-909.
Vainio, P. J., Viluksela, M., Tuominen, R. K. (1998). Nicotine-like effects of cotinine on protein kinase C activity and noradrenaline release in bovine adrenal chromaffin cells. J. Auton. Pharmacol. 18:245-250.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Riah, O., Dousset, JC., Bofill-Cardona, E. et al. Isolation and Microsequencing of a Novel Cotinine Receptor. Cell Mol Neurobiol 20, 653–664 (2000). https://doi.org/10.1023/A:1007094623775
Issue Date:
DOI: https://doi.org/10.1023/A:1007094623775